Literature DB >> 6678745

Teratogenic effects of D-penicillamine in rats: relation to copper deficiency.

C L Keen, P Mark-Savage, B Lönnerdal, L S Hurley.   

Abstract

The teratogenicity of D-penicillamine (DP) (dimethyl cysteine) was studied using the Sprague-Dawley rat. D-Penicillamine was fed during pregnancy at a level of 0 (control), 0.17, 0.83, or 1.66% of the diet. The frequency of resorptions, and the frequency and severity of malformations, increased with increasing levels of the drug. Maternal and fetal tissue copper levels were significantly lower in the DP groups than in controls, with the levels decreasing in a dose-related manner. Maternal and fetal zinc levels were lower in the 1.6% DP group than in controls. Maternal liver iron concentration was higher in the drug-fed rats than in controls, increasing in a dose-related manner. Fetal iron concentration was not consistently affected by the drug. Maternal and fetal manganese, calcium, and magnesium concentrations were similar among all groups. These results suggest that the teratogenicity of D-penicillamine may be due in part to induction of copper deficiency and, at high dose levels, zinc deficiency, caused by its chelating properties.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6678745

Source DB:  PubMed          Journal:  Drug Nutr Interact        ISSN: 0272-3530


  5 in total

1.  Wilson's disease: A review of what we have learned.

Authors:  Kryssia Isabel Rodriguez-Castro; Francisco Javier Hevia-Urrutia; Giacomo Carlo Sturniolo
Journal:  World J Hepatol       Date:  2015-12-18

2.  Effects of manganese deficiency on pyruvate carboxylase and phosphoenolpyruvate carboxykinase activity and carbohydrate homeostasis in adult rats.

Authors:  D L Baly; C L Keen; L S Hurley
Journal:  Biol Trace Elem Res       Date:  1986-12       Impact factor: 3.738

3.  Copper deficiency and hyperlipoproteinemia induced by a tetramine cupruretic agent in rabbits.

Authors:  S A Hing; K Y Lei
Journal:  Biol Trace Elem Res       Date:  1991-03       Impact factor: 3.738

Review 4.  Liver disease in pregnancy.

Authors:  Noel M Lee; Carla W Brady
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

Review 5.  Optimisation of antirheumatic drug treatment in pregnancy.

Authors:  M Ostesen
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.